Sang Yi - 21 Feb 2023 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role: President, Asia Pacific
Signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Sang Yi (power of attorney previously filed)
Issuer symbol: ZBH
Transactions as of: 21 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 23 Feb 2023, 16:55:46 UTC
Previous filing: 03 Mar 2022
Next filing: 08 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZBH	Common Stock	Options Exercise	$0	+2,423	+40%	$0.000000	8,527	21 Feb 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZBH	Restricted Stock Units	Award	$0	-2,423	-100%	$0.000000^*	0	21 Feb 2023	Common Stock	2,423		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.
F2	Includes 268 shares acquired under the Company's Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 2, 2023.
F3	Each RSU represents a contingent right to receive one share of Company common stock.